Respiro Diagnostics
PrivateLast Round
Pre Seed
Jul 8, 2026
Total Funding Raised
$1.34M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Respiro Diagnostics operates in Healthcare & Life Sciences and is based in Leeds. Its latest recorded funding round was a Pre Seed round in July 2026.
Respiro Diagnostics is a biotechnology company that develops a breath-based diagnostic platform for the non-invasive detection and molecular profiling of lung cancer and other respiratory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Respiro Diagnostics Comparables
Compare Respiro Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vocxi Health | 82% | |
| Bioxhale Ltd | 81% | |
| Menssana Research Inc. | 78% |
For institutional investors. Book with your work email.
Respiro Diagnostics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Respiro Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amadeus Capital Partners | Pre Seed |
| Zinc | Pre Seed |
| Innovate UK | Pre Seed |
| The Francis Crick Institute | Pre Seed |
| SFC Capital | Pre Seed |
| ConceptionX | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 8, 2026
$1.34M round led by SFC Capital and Zinc
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingNov 12, 2026
Respiro Diagnostics is developing a breath analysis test that detects diseases through chemical signatures in human breath, with research focused on identifying lung cancer before symptoms emerge.
For institutional investors. Book with your work email.
Respiro Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Respiro Diagnostics's valuation, stock price, and market status.
Is Respiro Diagnostics a public or private company?
Respiro Diagnostics is a private company.
What is the current stock price of Respiro Diagnostics?
Respiro Diagnostics is a private company, so its shares have no public market price. Caplight tracks Respiro Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Respiro Diagnostics worth (valuation)?
Valuation information for Respiro Diagnostics is not publicly available.
Can I buy Respiro Diagnostics stock?
Respiro Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Respiro Diagnostics's last funding round?
Respiro Diagnostics's most recent funding round was Pre Seed on July 8, 2026.
Who are the main investors in Respiro Diagnostics?
Key investors in Respiro Diagnostics include Zinc, SFC Capital.
Will Respiro Diagnostics IPO soon?
No public IPO plans have been announced for Respiro Diagnostics.
How can I track Respiro Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Respiro Diagnostics's shares on secondary markets.